Bar Harbor Wealth Management Sells 6,585 Shares of Lam Research Corporation $LRCX

Key Points

• Bar Harbor Wealth Management sold 6,585 shares of Lam Research in Q4 (a 12.6% reduction), leaving it with 45,806 shares valued at about $7.84 million.
• There has been notable insider selling: CFO Douglas Bettinger sold 50,057 shares (~$11.2M) and Director Eric Brandt sold 35,000 shares, with insiders selling 130,886 shares worth roughly $29.66M over the last 90 days.
• Analysts remain broadly bullish—several firms raised price targets (Susquehanna to $350) and the consensus is a "Moderate Buy" with an average target near $246, supported by Lam's recent earnings beat and raised guidance.

Bar Harbor Wealth Management lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 12.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 45,806 shares of the semiconductor company's stock after selling 6,585 shares during the period. Bar Harbor Wealth Management's holdings in Lam Research were worth $7,841,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of LRCX. PMV Capital Advisers LLC bought a new position in shares of Lam Research during the fourth quarter valued at $25,000. Stance Capital LLC bought a new position in Lam Research during the third quarter worth $26,000. Triumph Capital Management bought a new position in Lam Research during the third quarter worth $27,000. Strategic Wealth Investment Group LLC bought a new position in Lam Research during the second quarter worth $29,000. Finally, Delos Wealth Advisors LLC bought a new position in Lam Research during the second quarter worth $30,000. Institutional investors own 84.61% of the company's stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Susquehanna raised its price target on LRCX to $350 (from $325) and kept a "positive" rating, signaling strong analyst conviction and implying roughly ~32.8% upside from the cited reference price — a catalyst that can drive buying interest. MarketScreener
• Positive Sentiment: 24/7 Wall St. published a bullish target of $253.16 on LRCX (14.7% upside vs. its reference price), citing strong earnings growth — another favorable independent valuation backing the recent rally. 24/7 Wall St. Article
• Positive Sentiment: Coverage noting an analyst upgrade (reported by AmericanBankingNews/Benzinga) has already coincided with intraday gains, reinforcing momentum as investors re-rate Lam on better-than-expected results and outlook trends. AmericanBankingNews
• Neutral Sentiment: A Yahoo Finance piece examines Lam’s valuation after recent share-price momentum, prompting investors to reassess whether the current multiple fairly reflects continued growth — relevant for longer-term position sizing. Yahoo Finance
• Negative Sentiment: Broader-market weakness linked to fading optimism over a U.S.–Iran ceasefire could pressure cyclical names, including semiconductor equipment suppliers like Lam, if risk-off flows intensify. Barchart

Insider Transactions at Lam Research

In other news, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares in the company, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Eric Brandt sold 35,000 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company's stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 130,886 shares of company stock worth $29,658,802. Company insiders own 0.31% of the company's stock.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $263.66 on Friday. The company's fifty day moving average price is $227.64 and its 200-day moving average price is $188.95. The firm has a market capitalization of $329.25 billion, a price-to-earnings ratio of 54.03, a PEG ratio of 2.76 and a beta of 1.78. Lam Research Corporation has a one year low of $61.14 and a one year high of $268.23. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping analysts' consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the prior year, the firm earned $0.91 EPS. The business's revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. On average, equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th were issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date was Wednesday, March 4th. Lam Research's dividend payout ratio is currently 21.31%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Citic Securities lifted their price target on shares of Lam Research from $165.00 to $275.00 and gave the company a "buy" rating in a research note on Friday, January 30th. KeyCorp restated a "sector weight" rating on shares of Lam Research in a report on Thursday, January 29th. Evercore set a $275.00 target price on shares of Lam Research in a research note on Thursday, January 29th. Sanford C. Bernstein boosted their target price on shares of Lam Research from $275.00 to $285.00 and gave the company an "outperform" rating in a research note on Monday, February 9th. Finally, Wells Fargo & Company boosted their target price on shares of Lam Research from $250.00 to $290.00 and gave the company an "overweight" rating in a research note on Thursday, January 29th. Twenty-seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of "Moderate Buy" and an average target price of $246.32.

Lam Research Company Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.